Greater Washington is so much more than a political “swamp.”
But that's the label a group of life science companies and nonprofits — led by Gaithersburg-based MedImmune — said Wednesday they are still fighting against as they try to sell the year-old BioHealth Capital Region brand.
As piece of a two-day BioHealth Capital Regional Forum that began Wednesday at MedImmune headquarters,the research and development arm of London-based AstraZeneca PLC (NYSE: AZN), organizers announced a modern website…
Source: bizjournals.com